Open AccessMyeloperoxidase and calprotectin; Any role as non-invasive markers for the prediction of ınflammation and fibrosis in non-alcoholic steatohepatitis?
Author(s) -
Ercan Bıçakcı,
Coşkun Özer Demirtaş,
Çiǧdem Ataizi Çelikel,
Goncagül Haklar,
Deniz Duman
Publication year - 2020
Publication title -
the turkish journal of gastroenterology/the turkish journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 28
eISSN - 2148-5607
pISSN - 1300-4948
DOI - 10.5152/tjg.2020.19403
Subject(s) - myeloperoxidase , calprotectin , medicine , steatohepatitis , gastroenterology , hepatic fibrosis , fibrosis , fatty liver , inflammation , pathology , disease , inflammatory bowel disease
Specific serum markers reflecting hepatic inflammation and fibrosis are required to tailor the treatment strategies in non-alcoholic steatohepatitis (NASH). We aimed to investigate the roles of myeloperoxidase (MPO) and calprotectin in predicting the hepatic inflammation status and disease severity in NASH.